News

Awards honors, prizes and achievements for the week of Feb. 26 - March 4.

Dr. Costantino Iadecola has long been at the vanguard of understanding the vascular drivers of Alzheimer's disease.

Pregnant women are increasingly choosing to deliver their babies outside of the hospital, with such births rising by 80 percent from 2009-2014 despite being associated with higher neonatal morbidity and mortality.

Laparoscopic surgery is poised to revolutionize liver donation.

Awards, honors, prizes and achievements for the week of Feb. 19 - Feb. 26.

Former Marine and New York City firefighter, John Martinelli shares his story about open-heart surgery at Weill Cornell Medicine.

For three decades, Dr. Stephen Hoffman has pursued a single goal: a malaria vaccine.

Dr. Paul N. Casale has been appointed executive director of NewYork Quality Care, the Accountable Care Organization (ACO) of NewYork-Presbyterian, Columbia and Weill Cornell Medicine.

Dr. Laurie H. Glimcher has been named president and chief executive officer of the Dana-Farber Cancer Institute in Boston.

Awards, honors, prizes and achievements for the week of Feb. 12 - Feb. 19.

By studying the use of electronic health records, Weill Cornell Medicine investigators aim to transform how patients receive medical care.

Nearly one in four women with early-stage breast cancer who undergo a partial mastectomy will need a second surgery within 90 days.

An investigative therapy given to mice blocks the overactive immune responses that are a hallmark of inflammatory bowel disease without impairing the body's ability to fight infection.

Four faculty members are named "most influential" researchers, and other awards, honors, prizes and achievements for the week of Feb. 5 - Feb. 12.

Scientists at Weill Cornell Medicine believe immunotherapy could be the best game plan to defeat cancer.

Cell phones treated for just 10 minutes in a new desktop-sterilization device were fully rid of germs, including those that may be responsible for common skin infections.

Weill Cornell Medicine, NewYork-Presbyterian, and Houston Methodist have established a new collaborative fellowship program to create highly trained bioethicists.

Remembering hypertension expert Dr. John Laragh '48.

A subset of treatment-resistant prostate cancer pathologically resembles small cell lung cancer rather than typical prostate cancer.